SCHEMBL30317564

SCHEMBL30317564

CC(C)[C@H](NC(=O)CNC(=O)CO)C(=O)N[C@@H](CCCNC(N)=O)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ C3AR1 Q16581 1/20 0.42
▸ FURIN P09958 8/20 0.39
▸ CTDSP1 Q9GZU7 1/20 0.37
▸ NOD1 Q9Y239 3/20 0.37
▸ PRSS1 P07477 1/20 0.36
▸ SHMT1 P34896 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KLK7 P49862 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ CTSB P07858 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ QRFPR Q96P65 1/20 0.35
▸ FOLH1 Q04609 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24191073 0.91 C3AR1 (0.42) C3AR1FURINCTDSP1NOD1PRSS1
SCHEMBL31319761 0.90 C3AR1 (0.41) C3AR1FURINCTDSP1NOD1PRSS1
SCHEMBL29620243 0.89 C3AR1 (0.42) C3AR1FURINCTDSP1NOD1PRSS1
SCHEMBL31666024 0.88 NOD1 (0.40) C3AR1FURINCTDSP1NOD1PRSS1
SCHEMBL2369351 0.86 C3AR1 (0.39) C3AR1FURINCTDSP1NOD1PRSS1
SCHEMBL29385639 0.85 C3AR1 (0.45) C3AR1FURINCTDSP1NOD1SHMT1
SCHEMBL30317567 0.85 C3AR1 (0.42) C3AR1FURINCTDSP1NOD1PRSS1
Trifluoroacetic Acid SCHEMBL23630136 0.85 QRFPR (0.39) C3AR1FURINCTDSP1PRSS1SHMT1
SCHEMBL24193304 0.85 C3AR1 (0.42) C3AR1FURINCTDSP1NOD1POLB
SCHEMBL23629902 0.84 MEN1 (0.44) C3AR1FURINPRSS1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250115546-A1 LINKERS FOR ANTIBODY DRUG CONJUGATES UNIV TEXAS (US) 2025-04-10 — — US disclosed
US-12084403-B2 Linkers for antibody drug conjugates THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2024-09-10 — — US disclosed
US-20240059647-A1 LINKERS FOR ANTIBODY DRUG CONJUGATES UNIV TEXAS (US) 2024-02-22 — — US disclosed
US-11629122-B2 Linkers for antibody drug conjugates THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-04-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250115546-A1 LINKERS FOR ANTIBODY DRUG CONJUGATES CD47, EPCAM, SDCBP C3AR1 1357/4885FURIN 572/4885CTDSP1 1842/4885
US-12084403-B2 Linkers for antibody drug conjugates CD47, EPCAM, SDCBP C3AR1 1357/4885FURIN 572/4885CTDSP1 1842/4885
US-20240059647-A1 LINKERS FOR ANTIBODY DRUG CONJUGATES CD47, EPCAM, SDCBP C3AR1 1357/4885FURIN 572/4885CTDSP1 1842/4885
US-11629122-B2 Linkers for antibody drug conjugates CD47, EPCAM, FCGRT C3AR1 1121/4885FURIN 570/4885CTDSP1 1468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback